<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CHLORZOXAZONE</span><br/>(klor-zox'a-zone)<br/><span class="topboxtradename">Paraflex<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">centrally acting skeletal muscle relaxant</span><br/><b>Prototype: </b>Cyclobenzaprine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Centrally acting skeletal muscle relaxant. Acts indirectly by depressing nerve transmission through polysynaptic pathways
         in spinal cord, subcortical centers, and brainstem; also possibly has a sedative effect.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effectively controls muscle spasms and pain associated with musculoskeletal conditions. Not effective for spastic or dyskinetic
         CNS disorders, e.g., cerebral palsy.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Symptomatic treatment of muscle spasm and pain associated with various musculoskeletal conditions.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Impaired liver function; pregnancy (category C), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with known allergies or history of drug allergies; history of liver disease; older adult patients.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Skeletal Muscle Relaxant</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg t.i.d. or q.i.d. (max: 3 g/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 20 mg/kg/d in 34 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food or meals to prevent gastric distress. If necessary, tablet may be crushed and mixed with food or liquid, e.g.,
            milk, fruit juice.
         </li>
<li>Store in tight container at 15°30° C (59°86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> GI:</span> Anorexia, heartburn, nausea, vomiting, constipation, diarrhea, abdominal pain, hepatotoxicity: jaundice, liver damage. <span class="typehead">CNS:</span>
<span class="speceff-common">Drowsiness, dizziness,</span> light-headedness, headache, malaise, overstimulation. <span class="typehead">Skin:</span> Erythema, rash, pruritus, urticaria, petechiae, ecchymoses. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol,</b>
<span class="classification">cns depressants</span> add to CNS depression. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 1 h.  <span class="typehead">Peak:</span>  14 h. <span class="typehead">Duration:</span>  34 h. <span class="typehead"> Distribution:</span>  Not known if crosses placenta or distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 66 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor ambulation during early drug therapy; some patients may require supervision.</li>
<li>Lab tests: Periodic liver function tests are advised in patients receiving long-term therapy even if sporadic.</li>
<li>
            							Note: Since chlorzoxazone metabolite may discolor urine, dark urine cannot be a reliable sign of a hepatotoxic reaction.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid activities requiring mental alertness, judgment, and physical coordination until reaction to drug is known, since sedation,
            drowsiness, and dizziness may occur.
         </li>
<li>Drug may discolor urine orange to purplish red, but this is of no clinical significance.</li>
<li>Discontinue drug and notify physician if signs of hypersensitivity (see Appendix F) or of liver dysfunction appear (abdominal
            discomfort, yellow sclerae or skin, pruritus, malaise, nausea, vomiting).
         </li>
<li>Check with physician before taking an OTC depressant (e.g., antihistamine, sedative, alcohol) since effects may be additive.</li>
<li>Do not breast feed while using this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>